Dennis PA - Search Results

1

Blumenthal GM, Dennis PA. Blumenthal GM, et al. Among authors: dennis pa. Eur J Hum Genet. 2008 Nov;16(11):1289-300. doi: 10.1038/ejhg.2008.162. Epub 2008 Sep 10. Eur J Hum Genet. 2008. PMID: 18781191 Free PMC article. Review.

2

Activation of the PI3K/Akt pathway and chemotherapeutic resistance.

West KA, Castillo SS, Dennis PA. West KA, et al. Among authors: dennis pa. Drug Resist Updat. 2002 Dec;5(6):234-48. doi: 10.1016/s1368-7646(02)00120-6. Drug Resist Updat. 2002. PMID: 12531180 Review.

3

Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.

Tsurutani J, West KA, Sayyah J, Gills JJ, Dennis PA. Tsurutani J, et al. Among authors: dennis pa. Cancer Res. 2005 Sep 15;65(18):8423-32. doi: 10.1158/0008-5472.CAN-05-0058. Cancer Res. 2005. PMID: 16166321

4

Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway.

Granville CA, Memmott RM, Gills JJ, Dennis PA. Granville CA, et al. Among authors: dennis pa. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):679-89. doi: 10.1158/1078-0432.CCR-05-1654. Clin Cancer Res. 2006. PMID: 16467077 Review.

5

Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues, novel lipid-based inhibitors of Akt.

Gills JJ, Holbeck S, Hollingshead M, Hewitt SM, Kozikowski AP, Dennis PA. Gills JJ, et al. Among authors: dennis pa. Mol Cancer Ther. 2006 Mar;5(3):713-22. doi: 10.1158/1535-7163.MCT-05-0484. Mol Cancer Ther. 2006. PMID: 16546986

6

PTEN hamartomatous tumor syndromes (PHTS): rare syndromes with great relevance to common cancers and targeted drug development.

Lopiccolo J, Ballas MS, Dennis PA. Lopiccolo J, et al. Among authors: dennis pa. Crit Rev Oncol Hematol. 2007 Sep;63(3):203-14. doi: 10.1016/j.critrevonc.2007.06.002. Epub 2007 Jul 20. Crit Rev Oncol Hematol. 2007. PMID: 17643312 Review.

7

Targeting Akt in cancer therapy.

LoPiccolo J, Granville CA, Gills JJ, Dennis PA. LoPiccolo J, et al. Among authors: dennis pa. Anticancer Drugs. 2007 Sep;18(8):861-74. doi: 10.1097/CAD.0b013e3280cc2c6f. Anticancer Drugs. 2007. PMID: 17667591 Review.

8

Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. LoPiccolo J, et al. Among authors: dennis pa. Drug Resist Updat. 2008 Feb-Apr;11(1-2):32-50. doi: 10.1016/j.drup.2007.11.003. Epub 2007 Dec 31. Drug Resist Updat. 2008. PMID: 18166498 Free PMC article. Review.

9

Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.

Memmott RM, Gills JJ, Hollingshead M, Powers MC, Chen Z, Kemp B, Kozikowski A, Dennis PA. Memmott RM, et al. Among authors: dennis pa. Cancer Res. 2008 Jan 15;68(2):580-8. doi: 10.1158/0008-5472.CAN-07-3091. Cancer Res. 2008. PMID: 18199555 Free PMC article.

10

Germline PTEN mutations as a cause of early-onset endometrial cancer.

Blumenthal GM, Dennis PA. Blumenthal GM, et al. Among authors: dennis pa. J Clin Oncol. 2008 May 1;26(13):2234; author reply 2234. doi: 10.1200/JCO.2007.15.8949. J Clin Oncol. 2008. PMID: 18445858 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

212 results

Search Page

Filters